Perioperative Treatment in Resectable Gastric Cancer with Spartalizumab (PDR001) in Combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT): A phase II study (GASPAR)
CompletedCTIS2024-516299-13-00
Centre Francois BaclesseResectable Gastric Cancer
Start: 2024-09-06End: 2025-11-27Target: 68Updated: 2024-09-05